2011-01-21 00:00:00,Biogen Idec Receives Negative Opinion From Committee For Medicinal Products For Human Use On FAMPYRA
2011-06-06 00:00:00,Biogen Idec Reports Positive Data From AVONEX Dose Titraion Study
2011-07-25 00:00:00,Biogen Idec Inc Receives Conditional Approval In European Union For FAMPYRA
2012-01-23 00:00:00,FDA Updates On Biogen Idec Inc and Elan TYSABRI Label To Include Virus Antibody Status As PML Risk Factor
2012-05-01 00:00:00,Biogen Idec Inc Updates FY 2012 Guidance
2012-07-05 00:00:00,Swedish Orphan Biovitrum AB and Biogen Idec Inc Initiate Global Clinical Trials of Hemophilia A and B Product Candidates in Children
2012-10-18 00:00:00,FDA Extends Review Of Biogen Idec Multiple Sclerosis
2012-10-26 00:00:00,Zacks Reiterates Neutral on Biogen Idec
